Latest news with #laboratory
Yahoo
6 days ago
- Business
- Yahoo
Morgan Stanley Hikes Labcorp (LH) Holdings Price Target to $283 Affirms ‘Overweight' Rating
Laboratory Corporation of America Holdings (NYSE:LH) is one of the best healthcare stocks to buy now. On June 11, Morgan Stanley reiterated the stock's 'Overweight' rating and raised the 12-month price target to $283 from $270. A scientist performing a blood test on a patient using life sciences tools & services. The adjustment underscores the investment firm's confidence in the company's growth prospects as it also faces durable demand for its products. LabCorp has already unveiled new product launches, including LabCorp Plasma Complete. It's also working on genetic risk label tests as part of its strategic focus on high-growth areas. Laboratory Corporation of America Holdings (NYSE:LH) is a global life sciences and healthcare company. It provides laboratory services for diagnosis, healthcare decisions, and drug development. Its services include clinical lab tests, drug development support, and testing for various conditions, including oncology, genetics, and infectious diseases. While we acknowledge the potential of LH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Stocks Analysts Are Upgrading Today and 13 Best AI Stocks to Buy Under $10. Disclosure: None.
Zawya
10-06-2025
- Health
- Zawya
SRTI Park and Roche collaborate with University of Sharjah to launch ‘My Green Lab' certification in the region
Sharjah, UAE – In a landmark step toward embedding sustainability into scientific and healthcare innovation, the Sharjah Research, Technology, and Innovation Park (SRTI Park) and Roche Diagnostics Middle East have announced the launch of the My Green Lab Certification (MGL) initiative, in partnership with the University of Sharjah (UoS) and the local implementation partner, Pharmatrade. This marks a leap in sustainable laboratory practices in healthcare, positioning Sharjah at the forefront of sustainable laboratory practices across the region. The initiative, which officially commences on June 3, 2025, will pilot the internationally recognized My Green Lab Certification within the University of Sharjah's research laboratories setting a precedent for academic, clinical, and industrial laboratories in the region. My Green Lab is the only laboratory sustainability certification endorsed by the UN-backed Race to Zero campaign, and is widely seen as the gold standard in advancing net-zero targets within the life sciences and healthcare industries. SRTI Park is positioning itself as the region's foremost advocate for sustainable innovation. With a growing portfolio of green technology pilots, climate-focused research hubs, and partnerships with global industry leaders, SRTI Park is actively embedding environmental sustainability into the fabric of R&D activity across the UAE. By championing the My Green Lab initiative, the Park is not only reinforcing its role as a convener of impactful collaborations, but also underscores its commitment to transforming Sharjah into a hub for environmentally responsible scientific advancement in the Middle East. UoS Research Institute of Medical and Health Sciences The collaboration reflects a strategic alliance between a public innovation platform and a global life sciences leader, aimed at transforming the environmental footprint of laboratory research through measurable, science-based improvements. The project is considered a landmark due to the significance of the collaboration between the three parties through UoS's Research Institute of Medical and Health Sciences which is pioneering breakthroughs that firmly connect academia and healthcare delivery. Roche: Advancing Sustainability in Diagnostics and Life Sciences As a global pioneer in healthcare innovation, Roche is at the forefront of integrating sustainability into the life sciences sector. This project is supported by Roche and its implementation partner Pharmatrade. By spearheading initiatives like My Green Lab Certification, Roche is enabling laboratories worldwide to adopt measurable, science-based sustainability practices. This collaboration exemplifies Roche's strategic vision to foster greener, more responsible scientific environments through cross-sector partnerships. A New Chapter in Healthcare Sustainability As sustainability becomes a cornerstone of responsible innovation, this initiative underscores Sharjah's emergence as a regional hub for sustainable healthcare R&D. The launch represents a convergence of academia, industry, and policy, and aims to establish a blueprint for reducing waste, energy use, and hazardous chemical exposure in laboratories—environments historically overlooked in sustainability frameworks. Hussain Al Mahmoudi, CEO of SRTI Park says: 'This project exemplifies Sharjah's commitment to pioneering solutions that serve global goals while fostering local capability. It is more than a certification—it is a regional movement toward sustainable science. With Roche and the University of Sharjah, we are planting the seeds of long-term environmental stewardship and setting a regional benchmark for clean innovation.' His Excellency Professor Esameldin Agmy, Chancellor of the University of Sharjah, expressed his pride in the institution's leadership in the region, stating, 'We are delighted to be at the forefront of leading academic institutions in the region that embrace environmental sustainability initiatives within scientific research. Our partnership with the Sharjah Research, Technology and Innovation Park and Roche to launch the 'My Green Lab' initiative is a strategic step toward realizing the University's vision of fostering environmentally responsible scientific research.' Professor Agmy also remarked on the University's advanced Institute of Medical and Health Sciences Research, which houses state-of-the-art laboratories dedicated to critical fields such as cancer, immunology, and medicine. He described the institute as the ideal platform for implementing the first phase of global environmental sustainability standards at the University. Emphasizing the strong link between research excellence and environmental responsibility, Professor Agmy noted, 'This initiative aligns with the University of Sharjah's comprehensive strategy to promote high-quality scientific research that both serves society and protects the environment. Through this collaboration, we aim to prepare a new generation of researchers and scientists who blend advanced research skills with environmental consciousness, equipping them to become leaders of change for a more sustainable future.' Concluding his remarks, Professor Agmy discussed the broader significance of the achievement, stating, 'Obtaining the certified 'My Green Lab' accreditation is not merely an academic milestone, but an institutional commitment to being a university of the future; a university that produces environmentally responsible and scientifically innovative scholars. This accomplishment further elevates Sharjah's status as a global hub for sustainable innovation in the Middle East.' Mohamed Al Omari Head of Diagnostics in the UAE at Roche added: 'This initiative is an important outcome of our MoU with SRTIP and reflects our commitment to building a sustainable, future-ready healthcare system. Sustainability in healthcare is no longer a choice… it is a necessity. By working closely with our ecosystem partners, including SRTIP and the academic community, we are co-creating actionable, scalable solutions that can drive real impact. We are also proud to enable this project with our longstanding implementation partner in the UAE, Pharmatrade.' Jihad Al Hussami, Senior Executive Manager at Pharmatrade LLC, commented: 'Pharmatrade is proud to support the seamless implementation of this important initiative, in collaboration with Roche and the University of Sharjah. Together, we are integrating innovative, eco-friendly solutions that align with our shared vision of building a more sustainable, efficient, and resilient healthcare system for the future.' Setting the Stage for a Broader Ecosystem Shift Dr. Asma Mahmoud Fikri, Director of Government and Corporate Partnerships at SRTI Park, commented: 'This collaboration is a clear articulation of SRTI Park's commitment to shaping a green innovation economy. Working with Roche and the University of Sharjah to deliver the My Green Lab Certification brings Sharjah closer to our vision of becoming a global reference point in sustainable science and healthcare.' The initiative also presents a wider opportunity to institutionalize green standards across Sharjah's healthcare and scientific infrastructure, particularly through deeper partnerships with entities such as Sheraa, the Sharjah Health Authority, and foundations committed to impact, such as The Big Heart Foundation. With Sharjah's expanding footprint in next-generation healthcare development—including projects like the Jawaher Boston Medical District—initiatives such as My Green Lab signal a strategic alignment between environmental responsibility and scientific leadership. The launch of the My Green Lab Certification is a tangible step in advancing the UAE's national sustainability agenda and aligns with Sharjah's vision to become a beacon of sustainable innovation in the Middle East.
BBC News
22-05-2025
- Science
- BBC News
State-of-the-art building approved for Oxford Science Park
A state-of-the-art laboratory building will be built at Oxford Science Park after city councillors gave it the park secured planning permission for the four-storey building, which will be built close to the closed pub, The Priory, the Ozone Leisure Park and the Kassam Stadium, on development will include 168 car parking spaces, electric charging points and just over 100 bike Shen, the park's director, said the approval was "fantastic news" and will help it deliver more "world-class facilities in an established setting that promotes collaboration, sustainability and discovery". The new building will sit on currently undeveloped land between the science park and the neighbouring cinema and bowling rink will not involve any part of the Ozone Leisure Park, which is itself the subject of a different plan that could lead to its redevelopment. You can follow BBC Oxfordshire on Facebook, X (Twitter), or Instagram.
Fast Company
16-05-2025
- Business
- Fast Company
From lab to market: Monetizing R&D
It's one thing to invent something cool within controlled laboratory environments. It's entirely another to scale that new baby for sale. The tension between innovation and commercialization is something we regularly wrestle with at Abstrax. Every morning, we don lab coats and ask the same question: 'How do you make money from research done in a lab?' Balance innovation with commercial reality Discovery for its own sake isn't enough. Many R&D-heavy companies discover that brilliant ideas can languish for years if they don't have a system for bringing them to market. We decided early on to build that bridge proactively. This meant investing heavily not just in research, but in the systems and machinery that connect lab work to real-world products. Our scientists don't concoct in ivory towers, they work hand-in-hand with product developers to ensure (most) experiments align with market needs. This pragmatic approach focuses our curiosity. We poured resources into advanced analytical technology. Among other exquisite toys, we operate an ultra-sensitive aroma analysis platform nicknamed OMNI. With it, we can break down a complex flavor into hundreds of molecular components and pinpoint the ones that matter. By capturing a '3D metabolite fingerprint' of a material (cannabis flower, hop varietals, etc.), we get a complete map of that sample's aroma chemistry. Why go to these extremes? Because understanding a flavor at that granular level is the key to replicating it, enhancing it, and ultimately monetizing it. We can identify over 500 distinct compounds in a single hop strain. That level of resolution lets us see opportunities others might miss, like the trace molecules that round out pineapple, or a sulfur compound responsible for 'skunky' notes. From breakthrough to beer glass To illustrate how lab research turns into revenue, take our recent work with Citra, one of the most celebrated hops in craft brewing. Citra's appeal lies in its remarkably juicy, complex flavor—think grapefruit, lime, peach, and passionfruit steamrolled into one. This tropical medley makes a Citra-hopped beer delicious. But here's the rub: Achieving that same flavor consistently at scale is hard. Hops are agricultural products, subject to the whims of weather and yearly variation. The Citra you get this year might not taste exactly like last year's crop. This is where our lab-to-market philosophy shines. Using OMNI, we profiled Citra's chemical makeup in exquisite detail. Armed with that 'blueprint,' we developed an Omni Hop Profile extract that mirrors Citra's flavor profile with uncanny accuracy. For brewers, this is a game-changer. Instead of being at the mercy of Mother Nature, they can rely on our Citra extract to deliver the exact same flavor in every batch, forever. And because it's made from botanically derived ingredients, it stays true to the clean-label standards brewers abide by. We even worked with veteran brewmasters on pilot brews to fine-tune the extract's performance in different beer styles. By the time our Citra profile hit the market, it was brewer-tested and production-ready. Our Citra victory highlights our core principle of reasonable innovation. We didn't stop at discovering what makes that hop special, we pushed to make it a tangible solution to a real problem. That is the essence of monetizing R&D: moving from 'Eureka!' to a viable SKU. No fluff, only real solutions In avant-garde industries like cannabis and craft beer, it's easy to get caught up in hype and bold claims. We prefer a different tack: Let the results speak. If we say our new formulation improves a beer's shelf-life or an extract boosts an IPA's aroma, we've got the data to back it up. Grounding innovation in evidence keeps us credible and ensures we stay focused on real market value. We also recognize that not every experiment will pan out, and that's okay. Part of our system is knowing never to become 100% pot committed. We'll test 10 ideas, then swiftly double down on the one or two that show commercial promise. By failing fast and smart, we conserve resources for the innovations that count. The new R&D playbook Our journey from lab to market hasn't been quick or easy. It took patience and a willingness to invest up front. But that patience is paying off. Today, Abstrax's approach is turning niche scientific insights into mainstream products. What others consider to be a cost center is our engine for growth. When scientists and strategists work in sync, every discovery is viewed through the lens of real-world impact. The healthy tension between invention and commercialization keeps us sharp. As it turns out, the lab and the market are pretty good at balancing each other.
Associated Press
08-05-2025
- Business
- Associated Press
My Green Lab Launches ACT Ecolabel 2.0: Setting the Global Standard for Sustainable Laboratory Products
SAN DIEGO, May 8, 2025 /3BL/ - My Green Lab® today proudly launches the ACT Ecolabel 2.0 program, an enhanced version of the only third-party verified ecolabel for laboratory products. Designed to advance Accountability, Consistency, and Transparency for the scientific industry, ACT Ecolabel 2.0 offers product-level data to support sustainability-driven purchasing decisions. Building on years of collaboration with scientists, manufacturers, procurement professionals, and sustainability experts, ACT Ecolabel 2.0 delivers a rigorous, standardized framework for assessing and communicating the environmental impact of laboratory products. 'ACT Ecolabel 2.0 represents the collective expertise behind the program and reflects our deep commitment to advancing sustainability in science through credible, actionable data,' said James Connelly, My Green Lab's CEO. 'The enhanced program is transforming how the scientific community approaches sustainability in the lab supply chain, through embedding impact reductions into purchasing decisions, product development, and long-term corporate strategies.' As sustainability becomes a critical priority for laboratory operations, procurement representatives, and product manufacturers, the ACT Ecolabel delivers a unified framework that supports better decision-making across the supply chain. It enables manufacturers to credibly showcase sustainability performance and empowers procurement teams to make informed, sustainability-aligned purchasing decisions with confidence. Jennifer Valsler, Director, Sustainable Procurement, AstraZeneca, says, 'The My Green Lab ACT Ecolabel 2.0 aligns with AstraZeneca's corporate sustainability goals, while providing a consistent benchmark to evaluate products for purchasing decision making. Participation from manufacturers will strengthen their response for sustainability requests, and a consistent third-party verified industry standard will spur innovation and drive supply chain impact reductions.' The market has responded enthusiastically: 26 leading manufacturers have already committed to ACT Ecolabel 2.0 certification of their products, joining the 46 already participating, signaling the growing importance of a trusted standard like ACT Ecolabel for environmental accountability in life sciences. The upgraded ACT Ecolabel program introduces a range of enhancements, including: The ACT Ecolabel offers meaningful benefits to both manufacturers and procurement teams to support sustainable product development and smarter purchasing decisions. With more than 1,700 certified products from over 60 participating manufacturers in the ACT Ecolabel database, the program has become a central resource for the growing global community focused on sustainability in laboratory operations. Explore the comprehensive certified product database and discover how the ACT Ecolabel can support and accelerate your organization's sustainability goals. Visit About My Green Lab My Green Lab® is a nonprofit environmental organization with a mission to build a global culture of sustainability in science. The organization is the world leader in developing internationally recognized sustainability standards for laboratories and laboratory products—bringing sustainability to the community responsible for the world's life-changing medical and technical innovations. Laboratories are some of the most resource-intensive spaces in any industry, but they don't have to be. By introducing a new perspective and proven best practices within a carefully crafted framework, My Green Lab has inspired tens of thousands of scientists and lab professionals to make positive changes in their labs by reducing the environmental impact of their work. My Green Lab® ACT® Ecolabel The first ecolabel for lab equipment and supplies that provides transparent, third-party verified data to help scientists and procurement teams make sustainable choices. Sixty companies and over 1,700 products currently have an ACT Ecolabel, with third-party verification provided by Verico. For media requests, contact Christina Creager at [email protected]. For more information about My Green Lab, visit Visit 3BL Media to see more multimedia and stories from My Green Lab
